999 filings
Page 5 of 50
424B5
ABIO
ARCA biopharma Inc
18 Mar 22
Prospectus supplement for primary offering
4:15pm
8-K
ABIO
ARCA biopharma Inc
14 Mar 22
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
4:26pm
10-K
2021 FY
ABIO
ARCA biopharma Inc
Annual report
14 Mar 22
4:06pm
SC 13G
BML Investment Partners, L.P.
27 Jan 22
ARCA biopharma / BML Investment Partners ownership change
3:53pm
4
Christopher David Ozeroff
16 Dec 21
ARCA biopharma / Christopher David Ozeroff ownership change
4:33pm
4
Thomas A Keuer
16 Dec 21
ARCA biopharma / Thomas A Keuer ownership change
4:32pm
4
C. Jeffrey Dekker
16 Dec 21
ARCA biopharma / C. Jeffrey Dekker ownership change
4:31pm
4
Bristow Michael R
16 Dec 21
ARCA biopharma / MICHAEL R BRISTOW ownership change
4:31pm
8-K
ABIO
ARCA biopharma Inc
16 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
ABIO
ARCA biopharma Inc
2 Dec 21
Topline readout of clinical trial results anticipated in first quarter of 2022
4:16pm
4
ABIO
ARCA biopharma Inc
23 Nov 21
ARCA biopharma / Christopher David Ozeroff ownership change
4:53pm
8-K
ABIO
ARCA biopharma Inc
2 Nov 21
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:31pm
10-Q
2021 Q3
ABIO
ARCA biopharma Inc
Quarterly report
2 Nov 21
4:05pm
8-K
ABIO
ARCA biopharma Inc
28 Oct 21
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy
4:38pm
8-K
ABIO
ARCA biopharma Inc
16 Sep 21
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
4:15pm
8-K
ABIO
ARCA biopharma Inc
9 Aug 21
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
4:16pm
8-K
ABIO
ARCA biopharma Inc
4 Aug 21
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:31pm
10-Q
2021 Q2
ABIO
ARCA biopharma Inc
Quarterly report
4 Aug 21
4:06pm
8-K
ABIO
ARCA biopharma Inc
28 Jul 21
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Analysis in full patient cohort shows Gencaro effect compared to standard of care
4:16pm
8-K
ABIO
ARCA biopharma Inc
13 Jul 21
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
8:15am